1 |
Reactive |
Based on weight loss ≥10% and intake <50% |
Yes |
2 |
Prophylactic upon indication and reactive |
Prophylactic based on criteria: very low BMI, large tumour, dysphagia. Reactive in case of severe complications during treatment and if nasogastric tube is not possible. Reactive often after CRT treatment |
No |
3 |
Prophylactic upon indication |
If tumour is localised in oropharynx, oral cavity or nasopharynx. If tumour is localised elsewhere, it is based on insufficient intake and weight loss |
Yes |
4 |
Reactive |
If nasogastric tube is not possible or not tolerated |
No |
5 |
Prophylactic upon indication and reactive |
Prophylactic on indication in case of treatment with cisplatin, reactive if enteral nutrition is necessary (but then nasogastric tube is used instead of PEG/PRG) |
No |
6 |
Prophylactic upon indication and reactive |
— |
No |
7 |
Prophylactic upon indication and reactive |
No clear indicators, but at least 10% weight loss before treatment and dysphagia at baseline |
No |
8 |
Prophylactic (in all patients) |
All patients receive a PEG/PRG tube prophylactic, unless it is not possible due to comorbidity. In that case, a nasogastric tube will be placed reactive |
Yes |
9 |
Prophylactic upon indication |
If nutritional status is insufficient before start of CRT treatment |
No |
10 |
Prophylactic upon indication |
In case of a primary tumour in oral cavity or oropharynx and/or bilateral neck irradiation |
No |
11 |
Prophylactic upon indication |
If the physician expects that swallowing problems will be minimal (5% of the cases), a PEG or PRG tube is not placed prophylactic. In other cases, PEG or PRG tubes are placed before the treatment starts |
Yes |
12 |
Prophylactic (in all patients) |
Prophylactic placement in almost every patient, except if there are contraindications or if the patients does not want a PEG or PRG tube. If the PEG tube is not placed prophylactic and tube feeding is needed in the last weeks of CRT, it will be provided via nasogastric tubes |
Yes |
13 |
Prophylactic upon indication |
When at least one of the following applies: (1) T3/T4 tumour in oral cavity, oropharynx or hypopharynx; (2) nasopharyngeal tumour; (3) bilateral neck irradiation; (4) weight loss >5% in one month or >10% in three months; (5) low BMI (<18.5 or <20 when age >65 years); (6) dysphagia with insufficient intake |
Yes |